National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 392855

History of Changes from the VAERS Wayback Machine

First Appeared on 7/31/2010

392855
VAERS Form:
Age:12.0
Gender:Female
Location:West Virginia
Vaccinated:2010-06-14
Onset:2010-06-16
Submitted:2010-07-13
Entered:2010-07-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1487Y / 0 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Facial palsy, Speech disorder

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: Vyvanse
Current Illness: Attention deficit/hyperactivity disorder
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: None
CDC 'Split Type': WAES1007USA00541

Write-up:Information has been received from a physician and a licensed practical nurse concerning a 12 year old female with attention deficit/hyperactivity disorder and no known drug allergies, who on 14-JUN-2010 was vaccinated with the first dose of GARDASIL (lot # 1487Y). Concomitant therapy included VYVANSE (for the attention deficit/hyperactivity disorder). No other vaccines were given on the day GARDASIL was administered. On 16-JUN-2010, the patient demonstrated symptoms of facial droop and impaired speech, so went to the ER (not admitted), and was diagnosed with bell''s palsy made based on symptoms. No diagnostic testing was performed. The patient was ordered oral ACYCLOVIR, oral PREDNISONE, and ophthalmic erythromycin ointment for 10 days. The patient went to follow-up with an ENT physician (no details). The patient was seen in office on 21-JUN-2010 and 06-JUL-2010, and was still recovering. The event was considered disabling, but not life threatening by the licensed practical nurse. Additional information has been requested.


Changed on 2/4/2011

392855 Before After
VAERS Form:
Age:12.0
Gender:Female
Location:West Virginia
Vaccinated:2010-06-14
Onset:2010-06-16
Submitted:2010-07-13
Entered:2010-07-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1487Y / 0 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Facial palsy, Speech disorder

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: Vyvanse
Current Illness: Attention deficit/hyperactivity disorder
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: None
CDC 'Split Type': WAES1007USA00541

Write-up:Information has been received from a physician and a licensed practical nurse concerning a 12 year old female with attention deficit/hyperactivity disorder and no known drug allergies, who on 14-JUN-2010 was vaccinated with the first dose of GARDASIL (lot # 1487Y). Concomitant therapy included VYVANSE (for the attention deficit/hyperactivity disorder). No other vaccines were given on the day GARDASIL was administered. On 16-JUN-2010, the patient demonstrated symptoms of facial droop and impaired speech, so went to the ER (not admitted), and was diagnosed with bell''s palsy made based on symptoms. No diagnostic testing was performed. The patient was ordered oral ACYCLOVIR, oral PREDNISONE, and ophthalmic erythromycin ointment for 10 days. The patient went to follow-up with an ENT physician (no details). The patient was seen in office on 21-JUN-2010 and 06-JUL-2010, and was still recovering. The event was considered disabling, but not life threatening by the licensed practical nurse. Additional information has been requested.


Changed on 3/11/2011

392855 Before After
VAERS Form:
Age:12.0
Gender:Female
Location:West Virginia
Vaccinated:2010-06-14
Onset:2010-06-16
Submitted:2010-07-13
Entered:2010-07-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1487Y / 0 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Facial palsy, Speech disorder

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: Vyvanse
Current Illness: Attention deficit/hyperactivity disorder
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: None
CDC 'Split Type': WAES1007USA00541

Write-up:Information has been received from a physician and a licensed practical nurse concerning a 12 year old female with attention deficit/hyperactivity disorder and no known drug allergies, who on 14-JUN-2010 was vaccinated with the first dose of GARDASIL (lot # 1487Y). Concomitant therapy included VYVANSE (for the attention deficit/hyperactivity disorder). No other vaccines were given on the day GARDASIL was administered. On 16-JUN-2010, the patient demonstrated symptoms of facial droop and impaired speech, so went to the ER (not admitted), and was diagnosed with bell''s palsy made based on symptoms. No diagnostic testing was performed. The patient was ordered oral ACYCLOVIR, oral PREDNISONE, and ophthalmic erythromycin ointment for 10 days. The patient went to follow-up with an ENT physician (no details). The patient was seen in office on 21-JUN-2010 and 06-JUL-2010, and was still recovering. The event was considered disabling, but not life threatening by the licensed practical nurse. Additional information has been requested.


Changed on 4/13/2011

392855 Before After
VAERS Form:
Age:12.0
Gender:Female
Location:West Virginia
Vaccinated:2010-06-14
Onset:2010-06-16
Submitted:2010-07-13
Entered:2010-07-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1487Y / 0 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Facial palsy, Muscular weakness, Speech disorder

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: Vyvanse
Current Illness: Attention deficit/hyperactivity disorder
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: None
CDC 'Split Type': WAES1007USA00541

Write-up:Information has been received from a physician and a licensed practical nurse concerning a 12 year old female with attention deficit/hyperactivity disorder and no known drug allergies, who on 14-JUN-2010 was vaccinated with the first dose of GARDASIL (lot # 1487Y). Concomitant therapy included VYVANSE (for the attention deficit/hyperactivity disorder). No other vaccines were given on the day GARDASIL was administered. On 16-JUN-2010, the patient demonstrated symptoms of facial droop and impaired speech, so went to the ER (not admitted), and was diagnosed with bell''s palsy made based on symptoms. No diagnostic testing was performed. The patient was ordered oral ACYCLOVIR, oral PREDNISONE, and ophthalmic erythromycin ointment for 10 days. The patient went to follow-up with an ENT physician (no details). The patient was seen in office on 21-JUN-2010 and 06-JUL-2010, and was still recovering. The event was considered disabling, but not life threatening by the licensed practical nurse. Additional information has been requested.


Changed on 5/13/2011

392855 Before After
VAERS Form:
Age:12.0
Gender:Female
Location:West Virginia
Vaccinated:2010-06-14
Onset:2010-06-16
Submitted:2010-07-13
Entered:2010-07-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1487Y / 0 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Facial palsy, Muscular weakness, Speech disorder

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: Vyvanse
Current Illness: Attention deficit/hyperactivity disorder
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: None
CDC 'Split Type': WAES1007USA00541

Write-up:Information has been received from a physician and a licensed practical nurse concerning a 12 year old female with attention deficit/hyperactivity disorder and no known drug allergies, who on 14-JUN-2010 was vaccinated with the first dose of GARDASIL (lot # 1487Y). Concomitant therapy included VYVANSE (for the attention deficit/hyperactivity disorder). No other vaccines were given on the day GARDASIL was administered. On 16-JUN-2010, the patient demonstrated symptoms of facial droop and impaired speech, so went to the ER (not admitted), and was diagnosed with bell''s palsy made based on symptoms. No diagnostic testing was performed. The patient was ordered oral ACYCLOVIR, oral PREDNISONE, and ophthalmic erythromycin ointment for 10 days. The patient went to follow-up with an ENT physician (no details). The patient was seen in office on 21-JUN-2010 and 06-JUL-2010, and was still recovering. The event was considered disabling, but not life threatening by the licensed practical nurse. Additional information has been requested.


Changed on 6/14/2014

392855 Before After
VAERS Form:
Age:12.0
Gender:Female
Location:West Virginia
Vaccinated:2010-06-14
Onset:2010-06-16
Submitted:2010-07-13
Entered:2010-07-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1487Y / 0 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Facial palsy, Speech disorder

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: Vyvanse
Current Illness: Attention deficit/hyperactivity disorder
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: None
CDC 'Split Type': WAES1007USA00541

Write-up:Information has been received from a physician and a licensed practical nurse concerning a 12 year old female with attention deficit/hyperactivity disorder and no known drug allergies, who on 14-JUN-2010 was vaccinated with the first dose of GARDASIL (lot # 1487Y). Concomitant therapy included VYVANSE (for the attention deficit/hyperactivity disorder). No other vaccines were given on the day GARDASIL was administered. On 16-JUN-2010, the patient demonstrated symptoms of facial droop and impaired speech, so went to the ER (not admitted), and was diagnosed with bell''s palsy made based on symptoms. No diagnostic testing was performed. The patient was ordered oral ACYCLOVIR, oral PREDNISONE, and ophthalmic erythromycin ointment for 10 days. The patient went to follow-up with an ENT physician (no details). The patient was seen in office on 21-JUN-2010 and 06-JUL-2010, and was still recovering. The event was considered disabling, but not life threatening by the licensed practical nurse. Additional information has been requested.


Changed on 4/14/2017

392855 Before After
VAERS Form:
Age:12.0
Gender:Female
Location:West Virginia
Vaccinated:2010-06-14
Onset:2010-06-16
Submitted:2010-07-13
Entered:2010-07-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1487Y / 0 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Facial palsy, Speech disorder

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: Vyvanse
Current Illness: Attention deficit/hyperactivity disorder
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: None
CDC 'Split Type': WAES1007USA00541

Write-up:Information has been received from a physician and a licensed practical nurse concerning a 12 year old female with attention deficit/hyperactivity disorder and no known drug allergies, who on 14-JUN-2010 was vaccinated with the first dose of GARDASIL (lot # 1487Y). Concomitant therapy included VYVANSE (for the attention deficit/hyperactivity disorder). No other vaccines were given on the day GARDASIL was administered. On 16-JUN-2010, the patient demonstrated symptoms of facial droop and impaired speech, so went to the ER (not admitted), and was diagnosed with bell''s palsy made based on symptoms. No diagnostic testing was performed. The patient was ordered oral ACYCLOVIR, oral PREDNISONE, and ophthalmic erythromycin ointment for 10 days. The patient went to follow-up with an ENT physician (no details). The patient was seen in office on 21-JUN-2010 and 06-JUL-2010, and was still recovering. The event was considered disabling, but not life threatening by the licensed practical nurse. Additional information has been requested.


Changed on 9/14/2017

392855 Before After
VAERS Form:(blank) 1
Age:12.0
Gender:Female
Location:West Virginia
Vaccinated:2010-06-14
Onset:2010-06-16
Submitted:2010-07-13
Entered:2010-07-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1487Y / 0 1 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Facial palsy, Speech disorder

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: Vyvanse
Current Illness: Attention deficit/hyperactivity disorder
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: None
CDC 'Split Type': WAES1007USA00541

Write-up:Information has been received from a physician and a licensed practical nurse concerning a 12 year old female with attention deficit/hyperactivity disorder and no known drug allergies, who on 14-JUN-2010 was vaccinated with the first dose of GARDASIL (lot # 1487Y). Concomitant therapy included VYVANSE (for the attention deficit/hyperactivity disorder). No other vaccines were given on the day GARDASIL was administered. On 16-JUN-2010, the patient demonstrated symptoms of facial droop and impaired speech, so went to the ER (not admitted), and was diagnosed with bell''s palsy made based on symptoms. No diagnostic testing was performed. The patient was ordered oral ACYCLOVIR, oral PREDNISONE, and ophthalmic erythromycin ointment for 10 days. The patient went to follow-up with an ENT physician (no details). The patient was seen in office on 21-JUN-2010 and 06-JUL-2010, and was still recovering. The event was considered disabling, but not life threatening by the licensed practical nurse. Additional information has been requested.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=392855&WAYBACKHISTORY=ON


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166